Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
ERESEARCHTECHNOLOGY INC (ERES)
|
Add to portfolio |
|
|
Price: |
$9.88
| | Metrics |
OS: |
49.4
|
M
| |
8
|
% ROE
|
Market cap: |
$488
|
M
| |
18
|
% ROIC
|
Net cash:
|
$24.7
|
M
| |
$0.50
|
per share
|
EV:
|
$463
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$46.3
|
M
| |
10.0
|
x EV/EBITDA
|
EBIT
|
$20.5
|
M
| |
22.6
|
x EV/EBIT
|
EPS |
$0.29
| |
33.9
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
Revenues | 184.9 | 141.0 | 93.8 | 133.1 | 98.7 | 86.4 | 86.8 | 109.4 |
Revenue growth | 31.2% | 50.3% | -29.5% | 34.9% | 14.3% | -0.6% | -20.6% | 63.7% |
Cost of goods sold | 56.1 | 73.6 | 44.3 | 58.9 | 48.6 | 44.5 | 38.7 | 36.3 |
Gross profit | 128.9 | 67.4 | 49.5 | 74.2 | 50.1 | 41.8 | 48.1 | 73.1 |
Gross margin | 69.7% | 47.8% | 52.8% | 55.8% | 50.7% | 48.4% | 55.4% | 66.8% |
Sales and marketing | 17.9 | 16.1 | 12.9 | 13.3 | 11.2 | 11.1 | 9.1 | 9.4 |
Research and development | 7.4 | 5.1 | 3.9 | 4.4 | 4.3 | 4.1 | 4.1 | 4.1 |
General and administrative | 31.0 | 30.6 | 14.9 | 18.2 | 12.3 | 14.7 | 11.5 | 10.3 |
EBIT | 19.5 | 15.6 | 17.9 | 38.4 | 22.3 | 12.0 | 23.4 | 49.4 |
EBIT margin | 10.5% | 11.1% | 19.1% | 28.8% | 22.5% | 13.9% | 27.0% | 45.1% |
Pre-tax income | 18.4 | 14.4 | 17.5 | 40.1 | 24.5 | 13.2 | 24.4 | 50.2 |
Income taxes | 4.7 | 4.6 | 6.8 | 15.1 | 9.2 | 4.9 | 9.0 | 20.5 |
Tax rate | 25.5% | 31.6% | 38.9% | 37.7% | 37.6% | 37.1% | 37.0% | 40.8% |
Net income | 13.7 | 9.9 | 10.7 | 25.0 | 15.3 | 8.3 | 15.4 | 29.7 |
Net margin | 7.4% | 7.0% | 11.4% | 18.8% | 15.5% | 9.6% | 17.7% | 27.2% |
|
Diluted EPS | $0.28 | $0.20 | $0.22 | $0.48 | $0.29 | $0.16 | $0.29 | $0.54 |
Shares outstanding (diluted) | 49.3 | 49.2 | 49.5 | 52.0 | 51.7 | 51.5 | 52.9 | 55.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|